ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,128Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 1187

$1.24M Total Retail Price of All Prescriptions

Rank: 16 out of 1187

444 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 444 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

4% of this provider’s 444 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 13,645 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FUROSEMIDE 738 667 1 8
AMLODIPINE BESYLATE 467 411 2 2
LEVOTHYROXINE SODIUM 368 305 3 3
OMEPRAZOLE 356 316 4 5
METFORMIN HCL 335 230 5 7
CRESTOR 334 242 6 16
WARFARIN SODIUM 293 265 7 13
SIMVASTATIN 280 236 8 1
ATORVASTATIN CALCIUM 255 168 9 6
METOPROLOL TARTRATE 238 227 10 10
POTASSIUM CHLORIDE 233 217 11 32
DONEPEZIL HCL 226 221 12 26
PREDNISONE 220 198 13 61
CARVEDILOL 217 164 14 19
METOPROLOL SUCCINATE 217 183 14 11
ADVAIR DISKUS 212 191 16 35
NAMENDA 208 208 17 44
CLOPIDOGREL 207 175 18 33
ZOLPIDEM TARTRATE 190 166 19 14
SPIRIVA 169 129 20 55
PANTOPRAZOLE SODIUM 160 150 21 42
DIGOXIN 154 128 22 65
LOSARTAN POTASSIUM 151 120 23 21
DIOVAN 148 122 24 17
PLAVIX 145 123 25 52
ENALAPRIL MALEATE 145 117 25 27
CLONIDINE HCL 138 101 27 73
PROAIR HFA 131 85 28 41
HYDROCHLOROTHIAZIDE 129 108 29 9
OXYCODONE-ACETAMINOPHEN 124 111 S2 30 47
NEXIUM 116 99 31 15
GLIMEPIRIDE 115 95 32 30
ALBUTEROL SULFATE 114 112 33 120
LYRICA 111 96 34 91
CLOTRIMAZOLE-BETAMETHASONE 110 101 35 100
LOSARTAN-HYDROCHLOROTHIAZIDE 107 100 36 56
DIOVAN HCT 105 83 37 40
LIDODERM 105 101 37 80
TRAMADOL HCL-ACETAMINOPHEN 102 82 39 102
RAMIPRIL 99 83 40 36
GABAPENTIN 99 92 40 23
GLYBURIDE 97 84 R 42 90
JANUVIA 96 87 43 34
ISOSORBIDE MONONITRATE ER 96 84 43 66
TRAMADOL HCL 96 77 43 28
ALLOPURINOL 92 74 46 50
LEVETIRACETAM 92 58 46 89
GLIPIZIDE 91 70 48 71
ESCITALOPRAM OXALATE 86 75 49 51
LISINOPRIL 86 77 49 4
LEVOFLOXACIN 86 74 49 74
SPIRONOLACTONE 86 56 49 98
PRAVASTATIN SODIUM 82 71 53 12
NITROGLYCERIN PATCH 80 76 54 138
ALENDRONATE SODIUM 79 58 55 25
CYMBALTA 78 72 56 60
CELEBREX 77 72 57 68
LACTULOSE 76 71 58 96
MEGESTROL ACETATE 75 75 R 59 185
CARBIDOPA-LEVODOPA 74 74 60 99
AZITHROMYCIN 74 53 60 24
PAROXETINE HCL 74 57 60 81
SINGULAIR 72 50 63 67
SERTRALINE HCL 72 56 63 22
ZETIA 72 59 63 64
SANTYL 70 70 66 150
BYSTOLIC 69 53 67 116
ENOXAPARIN SODIUM 69 62 67 282
MUPIROCIN 67 65 69 127
POLYETHYLENE GLYCOL 3350 67 51 69 86
RISPERIDONE 67 63 69 58
NOVOLOG 67 67 69 135
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 48 73 39
BACTROBAN 63 61 74 362
CITALOPRAM HBR 63 58 74 45
TAMSULOSIN HCL 62 57 76 29
LOVAZA 60 33 77 53
FAMOTIDINE 59 48 78 48
NOVOLOG FLEXPEN 59 58 78 171
SYMBICORT 59 52 78 176
FLUTICASONE PROPIONATE 58 50 81 31
AMIODARONE HCL 58 56 81 205
CALCITRIOL 58 58 81 320
LIPITOR 57 46 84 43
BENICAR HCT 55 28 85 170
LANTUS SOLOSTAR 55 40 85 92
FENTANYL 54 54 S2 87 82
BUDESONIDE 53 52 88 265
DEXILANT 52 42 89 137
MELOXICAM 51 47 90 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.